Henry C. Pitot
Impact in
- Hepatology top 0.1%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Biochemistry top 0.05%
- Amino Acid Enzymes and Metabolism
Papers in
- Oncology 161
- Drug Transport and Resistance Mechanisms 42
- Cancer-related Molecular Pathways 38
- Colorectal Cancer Treatments and Studies 32
- Co-authors
- George K. Michalopoulos (8 shared papers)William F. Dove (4 shared papers)Gerald L. Sattler (38 shared papers)Amy Moser (1 shared paper)Richard M. Goldberg (34 shared papers)Daniel J. Sargent (24 shared papers)Steven R. Alberts (27 shared papers)Paul F. Lambert (19 shared papers)
- Journals
- Journal of Clinical Oncology (62 papers)Journal of Biological Chemistry (33 papers)Archives of Biochemistry and Biophysics (25 papers)Carcinogenesis (23 papers)Biochemical and Biophysical Research Communications (15 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Henry C. Pitot
565 papers receiving 24.6k citations
Henry C. Pitot's Hit Papers
Peers
Comparison fields: 5 of 185
- Hepatology 2.9k
- Biochemistry 2.2k
- Cancer Research 4.1k
- Oncology 7.1k
- Pharmacology 1.7k
Countries citing papers authored by Henry C. Pitot
This map shows the geographic impact of Henry C. Pitot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry C. Pitot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry C. Pitot more than expected).
Fields of papers citing papers by Henry C. Pitot
This network shows the impact of papers produced by Henry C. Pitot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry C. Pitot. The network helps show where Henry C. Pitot may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry C. Pitot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 576 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer Hit paper breakdown → | 2003 | 1820 |
| 2 | A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse Hit paper breakdown → | 1990 | 1264 |
| 3 | Primary culture of parenchymal liver cells on collagen membranes Hit paper breakdown → | 1975 | 720 |
| 4 | The stages of initiation and promotion in hepatocarcinogenesis Hit paper breakdown → | 1980 | 430 |
| 5 | 2003 | 425 | |
| 6 | Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 Hit paper breakdown → | 2011 | 405 |
| 7 | 1993 | 403 | |
| 8 | 2005 | 354 | |
| 9 | 1986 | 353 | |
| 10 | 1978 | 345 | |
| 11 | Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. | 1980 | 309 |
| 12 | 1985 | 274 | |
| 13 | 2006 | 257 | |
| 14 | 1996 | 246 | |
| 15 | 2008 | 243 | |
| 16 | Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. | 2000 | 222 |
| 17 | 1997 | 220 | |
| 18 | 1979 | 217 | |
| 19 | 1996 | 212 | |
| 20 | 2010 | 210 |
About Henry C. Pitot
Henry C. Pitot is a scholar working on Molecular Biology, Oncology, Cancer Research, Biochemistry and Surgery, having authored 576 papers that have together received 26.2k indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (58 papers), Drug Transport and Resistance Mechanisms (42 papers), Carcinogens and Genotoxicity Assessment (41 papers), Cancer-related Molecular Pathways (38 papers), Metabolism and Genetic Disorders (38 papers), Colorectal Cancer Treatments and Studies (32 papers), Liver physiology and pathology (32 papers) and Pharmacogenetics and Drug Metabolism (28 papers). The work is most often cited by research in Hepatology (2.9k citations), Biochemistry (2.2k citations), Cancer Research (4.1k citations), Oncology (7.1k citations) and Pharmacology (1.7k citations). Henry C. Pitot has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include George K. Michalopoulos, William F. Dove, Gerald L. Sattler, Amy Moser, Richard M. Goldberg, Daniel J. Sargent, Steven R. Alberts, Paul F. Lambert, Yvonne P. Dragan and Carl Peraino. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, Archives of Biochemistry and Biophysics, Carcinogenesis and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.